Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Wait and see Funny Gut - wait and see
The drab Crystal ball watcher that hasn’t a Scooby and the opposite of Funny
RiverFort gave us all an opportunity to make some quick money as they have. Anyone who did not buy earlier and sell this week in my mind is going to regret it. We will now see a decline over te next few weeks to the mid-teens, with no positive RNS to boost the price. I had to laugh at the abundance of postings on the lines of
it used to be 450p so its going back to that and probably 150p in the next few weeks and the plethora of old news to say why SAR is worth over 1-2 bn.
RiverFort do this as a business and they gave us all an opportunity. as i said this is a short term play , nothing else
RNS due in the next 8 weeks (betting on a late May drop) for which we know SAD trial was successful, Food Interaction trial no issues.
MAD trial being finalised then we get the RNS. Musing if this has already been factored in, I don’t think it has. Like many on here I believe the MC is way too low at £30m.
Just as the air has been let out of the share price over the last year, it must be adjusted back now, given the imminent P1 report drop.
I also wonder why the board did not go for a more significant raise, enough to restart 1802? They must be confident they have a deal in time before our cash runway runs out again.
oh and not to forget the possible 737 update. What have the new owners been up to with that over the last few months?
Hi AOTD - I suspect those dates were simply chosen as suitable 'place holders' when completing the trial docs. They would push the dates out far enough to build in any potential slippage since they couldn't possibly know how many volunteers would sign up and when. The last advert looking for recruits was taken off the Nucleus Network website around 6th Jan. so I'd expect them to have enrolled the final subjects by the end of that month.
'often referred to as a blow off top'....
say no more. 😁😂😂
The (MAD) portion of SDC-1801 is nearing completion, not the whole trial.
According to here: last patient enrollment 7 May 24, last data collection 4 June 24
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12623000416695
But Basil if you've made 200% on a share it's actually disciplined investing to take profits. I haven't as I'm underwater on my earlier purchases here but I can see why others have.
"The multiple ascending dose (MAD) portion of SDC-1801 is nearing completion. Sareum aims to conclude this part of the trial by the end of Q2 2024. Subject to data review, additional funding and/or potential licencing opportunities, we endeavour to be in a position to commence a Phase 2a study in psoriasis patients before the end of 2024."
Top-line data is expected to be available in Q2 2024 was the wording on the Half-year report of 28 March 2024. We are already a month into Q2 2024, so it is due soon.
Who says the rns is due is days of maybe weeks ?
I'm expecting to see it drift a bit lower and consolidate after a fantastic 200%+ rise from the 8p area
Thats quite a run given the market we are in
Think most would be happy to hold in the 20p range over the coming weeks
Still 100%+ up from the lows and the 10p placing
There's a lot of chat about base prices, where the SP is going and support etc.
Very difficult to pin anything like that down due to the subscription shares being issued on Friday, there's still some RF selling to come. That is the one thing holding back the SP at the moment, when they clear their final tranche, we should see some stabilisation to more realistic levels, possibly likely to coincide with news.
For now GLA and see you in a few months for the Phase 1 RNS
I would prefer to see a higher base SP prior to the news release. It's still very low atm.
You may be right but I dont think there are many seller bellow 30p and I don't think it gapped up, it gapped down so I think the gaps are filled.
With topline data for the P1 trial of SDC-1801 due out very soon it is certainly risky to be day trading SAR between now and that RNS, especially as we know that to date SDC-1801 has been highly effective. e.g. it has already demonstrated a profile superior to the anti-inflammatory steroid dexamethasone and similar to the JAK1/JAK2 inhibitor baricitinib. When that data was RNS'd on July 1st 2021 the share price climbed over the next few weeks to over 450p. If we get a similar positive RNS from Oz in the coming days / weeks we should see a significant climb in the Sareum share price.
Lets check in tomorrow and see. When a stock gaps up and spikes like this then reverses same day. Its often refered to as a blow off top
Closing the daily at the lows indicates more downside tomorrow
I don't make the rules
Imo, the re-trace is done, and this is the new trading range.
IG - who do you work for.. oh hang on… that’s a very large portfolio and lots of your GCM predictions haven’t come to pass.
Fine that you express your opinion but forgive us if we just follow the news and the science. Thanks though
Not desperate, just saying it how it is
I said the same on GDR when it spiked to 10p... Cooled off back to 5p now
In this market a 250% rise from the lows requires some back testing and consolidation before continuing higher
20p is an obvious place for ap ullback imho
How about needs to get back to 100p level to consolidate as been way way oversold
I agree, it will hopefully slowly climb over the next few days and gain momentum. It's only this low due to profit takers from this morning.
Plenty of support @30p the last time I looked.
You seem desperate genius ....this will not go to 20p but good luck....